DVYSR — Devyser Diagnostics AB Balance Sheet
0.000.00%
- SEK1.84bn
- SEK1.69bn
- SEK169.30m
Annual balance sheet for Devyser Diagnostics AB, fiscal year end - December 31st, SEK millions except per share, conversion factor applied.
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | PROSPECTUS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Cash and Equivalents | |||||
Cash and Short Term Investments | 10.4 | 8.34 | 378 | 364 | 263 |
Net Total Accounts Receivable | |||||
Net Total Receivables | 17.2 | 25.1 | 26.2 | 33.3 | 45.3 |
Total Inventory | |||||
Prepaid Expenses | |||||
Total Other Current Assets | |||||
Total Current Assets | 32.4 | 39.7 | 413 | 412 | 342 |
Gross Property, Plant And Equipment | |||||
Accumulated Depreciation | |||||
Net Property, Plant And Equipment | 18.2 | 15.5 | 16.7 | 30.5 | 91.6 |
Net Goodwill | |||||
Net Intangible Assets | |||||
Long Term Investments | |||||
Long Term Notes Receivable | |||||
Other Long Term Assets | |||||
Total Assets | 73.7 | 74.4 | 457 | 501 | 510 |
Accounts Payable | |||||
Accrued Expenses | |||||
Notes Payable / Short Term Debt | |||||
Current Portion of Long Term Debt / Capital Leases | |||||
Total Other Current Liabilities | |||||
Total Current Liabilities | 15.9 | 28 | 29.4 | 51.2 | 62.9 |
Long Term Debt | |||||
Capital Lease Obligations | |||||
Total Long Term Debt | |||||
Total Debt | |||||
Deferred Income Tax | |||||
Total Other Liabilities | |||||
Total Liabilities | 36.7 | 43.6 | 40.2 | 69.2 | 125 |
Common Stock | |||||
Additional Paid In Capital | |||||
Retained Earnings (Accumulated Deficit) | |||||
Other Equity | |||||
Total Equity | 37 | 30.8 | 417 | 431 | 385 |
Total Liabilities & Shareholders' Equity | 73.7 | 74.4 | 457 | 501 | 510 |
Total Common Shares Outstanding |